Clinical Trial Update: Impact of Donor and Recipient ST2 / IL-33 Pathway After Heart Transplantation

View source ↗

Summary

Clinical trial update exploring the impact of donor and recipient ST2/IL-33 pathway after heart transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Transplant Rejection

Snippet

Sponsor: Groupe Hospitalier Pitie-Salpetriere | Conditions: Heart Transplant Failure and Rejection | Status: UNKNOWN